Parkinson's Disease Tulip


advertisement
Reply
 
Thread Tools Display Modes
Old 03-03-2014, 04:45 PM #1
Tupelo3 Tupelo3 is offline
Member
 
Join Date: Mar 2013
Location: New Jersey
Posts: 832
10 yr Member
Tupelo3 Tupelo3 is offline
Member
 
Join Date: Mar 2013
Location: New Jersey
Posts: 832
10 yr Member
Default FDA Grants “Orphan Drug” Status for Genervon’s Multi-Target ALS and PD Drug GM604

FDA Grants “Orphan Drug” Designation for Genervon’s Breakthrough Multi-Target ALS Bio-Drug GM604

This is great news for both ALS and PD patients. There are three concurrent ongoing studies for ALS, PD and Stroke patients. I am enrolled in the PD study and have finished all of my infusions.

GM6, Motoneuronotrophic factor (MNTF), is a neurotrophic molecule that binds on very specific receptors of the nervous system. It is an integral component of human fetal development. It is able to correct inadvertent errors in that development and thus be life sustaining and potentially therapeutic.

Throughout the embryonic development process, there are crucial regulatory pathways that oversee cell proliferation/apoptosis, differentiation, repair, inflammation/anti-inflammation, and overall developmental balance. MNTF is a specific master regulator that participates in regulating embryonic nervous system development. It is likely such a multi-functional master regulator that will have neurological protective qualities.

In a variety of in vitro and animal studies, GM6 has shown neuroregenerative and neuroprotective properties. MNTF has been shown to have neuroprotective and anti-apoptotic properties as well and may play a role in stem cell differentiation into motoneurons. These findings indicate that GM6 is a promising treatment for Parkinson’s disease, Alzheimer’s disease, spinal cord injuries, amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS) and Huntington’s disease.

Feel free to message me if you would like more details about GM6 (MNTF).

http://www.businesswire.com/news/hom...h#.UxTzzcuYaP8
Tupelo3 is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
anagirl (03-03-2014), Betsy859 (03-04-2014), Conductor71 (03-04-2014), Drevy (03-04-2014), johnt (03-05-2014), lab rat (03-03-2014), Lemonlime (03-04-2014), lurkingforacure (03-03-2014), Nan Cyclist (03-03-2014), soccertese (03-04-2014), Stand Tall (03-04-2014), wxxu (03-03-2014)

advertisement
Old 03-03-2014, 09:23 PM #2
anagirl anagirl is offline
Member
 
Join Date: Aug 2012
Location: San Francisco
Posts: 199
10 yr Member
anagirl anagirl is offline
Member
 
Join Date: Aug 2012
Location: San Francisco
Posts: 199
10 yr Member
Default

Gary~

Have you noticed any improvements in your symptom? Or is it too early to tell?
This sounds really promising!

Quote:
Originally Posted by Tupelo3 View Post
FDA Grants “Orphan Drug” Designation for Genervon’s Breakthrough Multi-Target ALS Bio-Drug GM604

This is great news for both ALS and PD patients. There are three concurrent ongoing studies for ALS, PD and Stroke patients. I am enrolled in the PD study and have finished all of my infusions.

GM6, Motoneuronotrophic factor (MNTF), is a neurotrophic molecule that binds on very specific receptors of the nervous system. It is an integral component of human fetal development. It is able to correct inadvertent errors in that development and thus be life sustaining and potentially therapeutic.

Throughout the embryonic development process, there are crucial regulatory pathways that oversee cell proliferation/apoptosis, differentiation, repair, inflammation/anti-inflammation, and overall developmental balance. MNTF is a specific master regulator that participates in regulating embryonic nervous system development. It is likely such a multi-functional master regulator that will have neurological protective qualities.

In a variety of in vitro and animal studies, GM6 has shown neuroregenerative and neuroprotective properties. MNTF has been shown to have neuroprotective and anti-apoptotic properties as well and may play a role in stem cell differentiation into motoneurons. These findings indicate that GM6 is a promising treatment for Parkinson’s disease, Alzheimer’s disease, spinal cord injuries, amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS) and Huntington’s disease.

Feel free to message me if you would like more details about GM6 (MNTF).

http://www.businesswire.com/news/hom...h#.UxTzzcuYaP8
anagirl is offline   Reply With QuoteReply With Quote
Old 03-03-2014, 10:38 PM #3
Tupelo3 Tupelo3 is offline
Member
 
Join Date: Mar 2013
Location: New Jersey
Posts: 832
10 yr Member
Tupelo3 Tupelo3 is offline
Member
 
Join Date: Mar 2013
Location: New Jersey
Posts: 832
10 yr Member
Default

Quote:
Originally Posted by anagirl View Post
Gary~

Have you noticed any improvements in your symptom? Or is it too early to tell?
This sounds really promising!
Ana, unfortunately I haven't yet been released by the research team to speak publicly about specific results. There is still one patient left that has to go through the trial and I wouldn't want to influence any results. In addition, I have no idea yet if I received the drug or the placebo. I probably won't find out for another month.

I'll keep you posted.
Tupelo3 is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
soccertese (03-04-2014)
Old 03-03-2014, 10:57 PM #4
anagirl anagirl is offline
Member
 
Join Date: Aug 2012
Location: San Francisco
Posts: 199
10 yr Member
anagirl anagirl is offline
Member
 
Join Date: Aug 2012
Location: San Francisco
Posts: 199
10 yr Member
Default

Ohhhhh - of course!! Well, I'll be anxious to hear.

Quote:
Originally Posted by Tupelo3 View Post
Ana, unfortunately I haven't yet been released by the research team to speak publicly about specific results. There is still one patient left that has to go through the trial and I wouldn't want to influence any results. In addition, I have no idea yet if I received the drug or the placebo. I probably won't find out for another month.

I'll keep you posted.
anagirl is offline   Reply With QuoteReply With Quote
Reply


Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off


Similar Threads
Thread Thread Starter Forum Replies Last Post
Cogane™ Granted Orphan Drug Status for Treatment of ALS neanderthal Parkinson's Disease 5 07-25-2012 12:45 PM
Isis' ALS Drug Gets Orphan-Drug Status BobbyB ALS News & Research 0 12-23-2007 07:13 PM
Isis' ALS Drug Gets Orphan-Drug Status BobbyB ALS News & Research 0 12-13-2007 10:43 PM
CoQ10/UBIQUINONE RECEIVES ORPHAN DRUG STATUS olsen Parkinson's Disease 1 11-16-2007 10:39 AM


All times are GMT -5. The time now is 02:15 AM.

Powered by vBulletin • Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.

vBulletin Optimisation provided by vB Optimise v2.7.1 (Lite) - vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.
 

NeuroTalk Forums

Helping support those with neurological and related conditions.

 

The material on this site is for informational purposes only,
and is not a substitute for medical advice, diagnosis or treatment
provided by a qualified health care provider.


Always consult your doctor before trying anything you read here.